New study: Venus White Pro whitens teeth up to 8.4 shades with virtually no sensitivity

Heraeus Kulzer, LLC, the leader in advancing dental esthetics and overall dental wellbeing, announced today the results of a new study that demonstrates that Venus White® Pro whitens teeth up to 8.4 shades with virtually no sensitivity. The results of the full clinical study will be presented during the International Association of Dental Research meeting, March 14 – 19, 2011.

The study, conducted by researchers at The University of Texas Health Science Center at Houston (UTHealth), was designed to evaluate the efficacy and color rebound effect of commercially available 22% carbamide peroxide (CP) Venus White® Pro at-home whitening system. The study also evaluated the sensitivity of Venus White® Pro.

A random selection of patient participants with no history of previous tooth whitening was recruited for the study. Subjects were treated nightly for two weeks with a maxillary custom tray containing Venus White® Pro with 22% carbamide peroxide and 3% potassium nitrate.

Conclusions

Whitening: Visual and instrumental measurements evaluation conclusively showed clinical whitening up to 8.4 times one week post bleaching. In general, color stabilized at two weeks post bleaching.

Sensitivity: On the sensitivity test, patients reported very low sensitivity levels with a mean value of "below 2" on a scale of 0-10, with zero representing no pain and 10 representing worst possible pain.

The study with UTHealth is part of Heraeus' ongoing research and development effort. The Company routinely collaborates with independent researchers and dental health care professionals at leading research universities and academic dental institutions to learn more treatment approaches as well as the efficacy of its products. "Our overriding goal for all Heraeus products is safety and effectiveness," says Christopher Holden, President of Heraeus Kulzer. "Our work isn't finished after a product is on the market. We continue to invest in controlled clinical studies, like the one with UTHealth, to make certain that our products and treatments are safe and effective and have the maximum positive impact on patients," he adds.

SOURCE Heraeus